<DOC>
	<DOCNO>NCT01543880</DOCNO>
	<brief_summary>This study conduct Europe . The aim study evaluate safety efficacy adult treat somatropin ( NorditropinÂ® ) .</brief_summary>
	<brief_title>Safety Efficacy Long-term Somatropin Treatment Adults</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<criteria>In need somatropin current user</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>